Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk

Therapeutic Drug Monitoring

Volumn 29, Issue 4, 2007, Pages 429-436

  Rezk, Naser L ^a   Abdel Megeed, Mohamed F ^a   Kashuba, Angela D M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiretroviral; Breast milk; Chromatography; High performance liquid chromatography; HIV; Mother to child transmission; Nonnucleoside reverse transcriptase inhibitor; Nucleoside reverse transcriptase inhibitor

Indexed keywords

LAMIVUDINE; MILK FAT; MILK PROTEIN; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BREAST MILK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG DETERMINATION; DRUG ISOLATION; DRUG MILK LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MILK, HUMAN; NEVIRAPINE; POSTPARTUM PERIOD; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; STAVUDINE; ZIDOVUDINE;

EID: 34547670520     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318074db39     Document Type: Article

References (22)

1. The Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
2. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries. JAMA. 2000;283:1175-1182.
3. Thior I, Shahin L, Smeaton L, et al. Breastfeeding Plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV Transmission in Botswana. JAMA. 2006;296:794-805.
4. Gaillard P, Fowler MG, Dabis F, et al., and the Ghent IAS Working Group on HIV in Women and Children. Use of antiretroviral drugs to prevent HIV-1 transmission through breast feeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr. 2004;35:178-187.
5. Rossi DT, Wright DS. Analytical considerations for trace determinations of drugs in breast milk. J Pharm Biomed Anal. 1997;15:495-504.
6. Rezk NL, Crutchley R, Yeh RF, et al. Full Validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring. Ther Drug Monit. 2006;28:517-525.
7. Lemmer P, Schneider S, Shuman M, et al. Determination of nevirapine and efavirenz in plasma using GC/MS in selecting ion monitoring mode. Ther Drug Monit. 2005;27:521-525.
8. US Department of Health and Human Services Food and Drug Administration. Guidance for Industry: Biological Method Evaluation. Available at: http://www.fda.gov/cder/guidance/. Accessed on June 1, 2006.
9. Van der Horst C, Fiscus S, Piwoz E, et al. Prevention of mother to infant transmission of HIV through breast feeding and reduction of morbidity and mortality of the breast feeding mothers: a study in Malawi. Antiviral Ther. 2003;8(Suppl 1):S477.
10. Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation: a revisit with a decade of progress. Pharm Res. 2000;17:1551-1557.
11. Rezk NL, Tidwell RR, Kashuba AD. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;791:137-147.
12. ESPGAN, Committee on Nutrition. Comment on the content and composition of lipids in infant formulas. Acta Paediatr Scand. 1991;69:654.
13. Lawrence RA. Breastfeeding, and medical disease. Med Clin North Am. 1989;73:583-603.
14. Fowler MG, Newell ML. Breast-feeding and HIV-1 transmission in resource-limited settings. J Acquir Immune Defic Syndr. 2002;30:230-239.
15. John-Stewart G, Mbori-Ngacha D, Ekipini R, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr. 2004;35:196-202.
16. Giovannini M, Riva E, Agostoni C. Fatty acids in pediatric nutrition. Pediatr Clin North Am. 1995;42:861-877.
17. Bitman J, Wood L, Metha NR, et al. Comparison of the phospholipid composition of breast milk from mothers of term and preterm infants during lactation. Am J Clin Nutr. 1984;40:1103-1119.
18. Burgoyne RD, Duncan JS. Secretion of milk proteins. J Mammary Gland Biol Neoplasia. 1998;3:275-286.
19. Zhang M, Moore GB, Gardinar S, et al. Determination of reofecoxib in human plasma and breast milk by high-performance liquid chromatographic assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;791:217-221.
20. Ohkubo T, Shimoyama R, Sugawara K, et al. Determination of chlorpromazine in human breast milk and serum by high-performance liquid chromatography. J Chromatogr. 1993;328-332.
21. Nitsun M, Szokol J, Saleh J, et al. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther. 2006;6:549-557.
22. Shapiro R, Holland D, Apparels E, et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Invest Dermatol. 2005;192:720-727.